VIVEK PARTHEEBAN
- USFDA observations minor in nature: Vivek Partheeban, CEO, Caplin PointIn an interview with ET Now, Vivek Partheeban, CEO, Caplin Point, speaks about resumption of supplies from a plant.01 Nov, 2016, 10.45 AM IST
We will continue to grow at 20-25%: Vivek Partheeban, Caplin Point Labs"Over 90 per cent of our revenues are still coming from Latin America and in the next couple of years we see the same trend continuing."08 Aug, 2016, 10.05 AM IST
Load More- USFDA observations minor in nature: Vivek Partheeban, CEO, Caplin Point